The Emerging Role of the Receptor for Advanced Glycation End Products on Innate Immunity

REFERENCES

• Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell 2010;140:805–820.
   PubMed Web of Science ®Google Scholar
• Janeway CA Jr. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today 1992;13:11–16.
   PubMedGoogle Scholar
• Lemaitre B, Nicolas E, Michaut L, The dorsoventral regulatory gene cassette Spaetzle/Toll/Cactus control the potent antifungal response in Drosophila adults. Cell 1996;86:973–983.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Coyne CB, PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunol Rev 2012;249:158–175.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
   PubMed Web of Science ®Google Scholar
• Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009;22:240–273.
   PubMed Web of Science ®Google Scholar
• Kumagai Y, Akira S. Identification and functions of pattern-recognition receptors. J Allergy Clin Immunol 2010;125:985–992.
   Google Scholar
• Kenny EF, O'Neill LA. Signalling adaptors used by Toll-like receptors: an update. Cytokine 2008;43:342–349
   PubMed Web of Science ®Google Scholar
• Rojas A, Figueroa H, Morales E. Fueling inflammation at tumor microenvironment: the role of multiligand/RAGE axis. Carcinogenesis 2010;31:334–341.
   PubMed Web of Science ®Google Scholar
• Sugaya K, Fukagawa T, Matsumoto K, Three genes in the human MHC class III region near the junction with the class II: gene for receptor of advanced glycosylation end products, PBX2 homeobox gene and a notch homolog, human counterpart of mouse mammary tumor gene int-3. Genomics 1994;23:408–419.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Stern MD. Receptor for age (RAGE) is a gene within the major histocompatibility class III region: implications for host response mechanisms in homeostasis and chronic disease. Front Biosci 2001;D1151–D1160.
   Google Scholar
• Neeper M, Schmidt AM, Brett J, Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 1992;267:14998–15004.
   PubMed Web of Science ®Google Scholar
• Fritz G. RAGE: a single receptor fits multiple ligands. Trends Biochem Sci 2011;36:625–632.
   PubMed Web of Science ®Google Scholar
• Raucci A, Cugusi S, Antonelli A, A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J 2008;22:3716–3727.
   PubMed Web of Science ®Google Scholar
• Parkin E, Harris B. A disintegrin and metalloproteinase (ADAM)-mediated ectodomain shedding of ADAM10. J Neurochem 2008;108:1464–1479.
   Google Scholar
• Zhang L, Bukulin M, Kojro E, Receptor for advanced glycation end products is subjected to protein ectodomain shedding by metalloproteinases. J Biol Chem 2008;283:35507–35516.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Piper MG, sRAGE induces human monocyte survival and differentiation. J Immunol 2010;185:1822–1835.
   PubMed Web of Science ®Google Scholar
• Xie J, Reverdatto S, Frolov A, Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem 2008;283:27255–27269.
   PubMed Web of Science ®Google Scholar
• Xie J, Burz DS, He W, Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem 2007;282:4218–4231.
   PubMedGoogle Scholar
• Zong A, Madden M, Ward M, Homodimerization is essential for the receptor for advanced glycation end products (RAGE)-mediated signal transduction. J Biol Chem 2010;285:23137–23146.
   PubMed Web of Science ®Google Scholar
• Kierdorf K, Fritz G. RAGE regulation and signaling in inflammation and beyond. J Leukoc Biol 2013;94:55–68.
   PubMed Web of Science ®Google Scholar
• Jedrzejas MJ. Pneumococcal virulence factors: structure and function microbiol Mol Biol Rev 2001;65:187–207.
   PubMed Web of Science ®Google Scholar
• Kislinger T, Fu C, Huber B, N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999;274:31740–31749.
   PubMed Web of Science ®Google Scholar
• Rojas A, Morales MA. Advanced glycation and endothelial functions: a link towards vascular complications in diabetes. Life Sci 2004;76:715–730.
   PubMedGoogle Scholar
• Rashid G, Luzon AA, Korzets Z, The effect of advanced glycation end-products and aminoguanidine on TNF-alpha production by rat peritoneal macrophages. Perit Dial Int 2001;21:122–129.
   PubMedGoogle Scholar
• Cohen MP, Shea E, Chen S, Shearman CW. Glycated albumin increases oxidative stress, activates NF-kappa B and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-beta 1 production in macrophage RAW cells. J Lab Clin Med 2003;141:242–249.
   PubMed Web of Science ®Google Scholar
• Alikhani Z, Alikhani M, Boyd CM, Advanced glycation end products enhance expression of pro-apoptotic genes and stimulate fibroblast apoptosis through cytoplasmic and mitochondrial pathways. J Biol Chem 2005;280:12087–12095.
   PubMedGoogle Scholar
• Schmidt AM, Yan S, Brett J, Regulation of human mononuclear phagocyte migration by cell surface-binding proteins for advanced glycation end products. J Clin Invest 1993;91:2155–2168.
   PubMed Web of Science ®Google Scholar
• Graves DT, Kayal RA. Diabetic complications and dysregulated innate immunity. Front Biosci 2008;13:1227–1239.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489–497.
   PubMed Web of Science ®Google Scholar
• Schmidt AM, Hori O, Cao R, RAGE: a novel cellular receptor for advanced glycation end products. Diabetes 1996;45(Suppl 3):S77–S80.
   Google Scholar
• Bhattacharyya N, Pal A, Patra S, Activation of macrophages and lymphocytes by methylglyoxal against tumor cells in the host. Int Immunopharmacol 2008;8:1503–1512.
   PubMed Web of Science ®Google Scholar
• Rojas A, Caveda L, Romay C, Effect of advanced glycosylation end products on the induction of nitric oxide synthase in murine macrophages. Biochem Biophys Res Commun 1996;225:358–362.
   PubMedGoogle Scholar
• Verdier Y, Zarándi M, Penkeq B. Amyloid beta-peptide interactions with neuronal and glial cell plasma membrane: binding sites and implications for Alzheimer's disease. J Pept Sci 2004;10:229–248.
   PubMed Web of Science ®Google Scholar
• Salminen A, Ojala J, Kauppinen A, Inflammation in Alzheimer's disease: amyloid-beta oligomers trigger innate immunity defence via pattern recognition receptors. Prog Neurobiol 2009;87:181–194.
   PubMed Web of Science ®Google Scholar
• Giri R, Shen Y, Stins M, Beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol 2000;279:C1772–C1781.
   PubMed Web of Science ®Google Scholar
• Turrin NP, Rivest S. Molecular and cellular immune mediators of neuroprotection. Mol Neurobiol 2006;34:221–242.
   PubMedGoogle Scholar
• Chavakis T, Bierhaus A, Al-Fakhri N, The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J Exp Med 2003;198:1507–1515.
   PubMed Web of Science ®Google Scholar
• Orlova VV, Choi EY, Xie C, A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 2007;26:1129–1139.
   PubMed Web of Science ®Google Scholar
• Frommhold D, Kamphues A, Hepper I, RAGE and ICAM-1 cooperate in mediating leukocyte recruitment during acute inflammation in vivo. Blood 2010;116:841–849.
   PubMedGoogle Scholar
• Foell D, Wittkowski H, Vogl T, Roth J. S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J Leukoc Biol 2007;81:28–37
   PubMed Web of Science ®Google Scholar
• Wolf R, Mirmohammadsadegh A, Walz A, Molecular cloning and characterization of alternatively spliced mRNA isoforms from psoriatic skin encoding a novel member of the S100 family. FASEB J 2003;17:1969–1971.
   PubMedGoogle Scholar
• Wolf R, Mascia F, Dharamsi A, Gene from a psoriasis susceptibility locus primes the skin for inflammation. Sci Transl Med 2010;2:61ra90.
   PubMedGoogle Scholar
• Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993;53:197–204.
   PubMed Web of Science ®Google Scholar
• Damo SM, Kehl-Fie TE, Sugitani N, Molecular basis for manganese sequestration by calprotectin and roles in the innate immune response to invading bacterial pathogens. Proc Natl Acad Sci USA 2013;110:3841–3846.
   PubMed Web of Science ®Google Scholar
• Andersson U, Tracey KJ. HMGB1 is a therapeutic target for sterile inflammation and infection. Ann Rev Immunol 2011;29:139–162.
   PubMed Web of Science ®Google Scholar
• Ito I, Fukazawa J, Yoshida M. Post-translational methylation of high mobility group box 1 (HMGB1) causes its cytoplasmic localization in neutrophils. The J Biol Chem 2007;282:16336–16344.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002;418:191–195.
   PubMed Web of Science ®Google Scholar
• Kazama H, Ricci JE, Herndon JM, Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 2008;29:21–32.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Fuji T, Ishijima R, The release of high mobility group box 1 in apoptosis is triggered by nucleosomal DNA fragmentation. Arch Biochem Biophys 2011;506:188–193.
   PubMed Web of Science ®Google Scholar
• Tang D, Kang R, Cheh CW, HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene 2010;29:5299–5310.
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Capobianco A, Scaffidi P, HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Rep 2004;5:825–830.
   PubMed Web of Science ®Google Scholar
• Messmer D, Yang H, Telusma G, High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004;173:307–313.
   Google Scholar
• Yang D, Chen Q, Yang H, High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 2007;81:59–66.
   PubMed Web of Science ®Google Scholar
• Degryse B, Bonaldi T, Scaffidi P, The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. J Cell Biol 2001;152:1197–1206.
   PubMed Web of Science ®Google Scholar
• Park JS, Arcaroli J, Yum HK, Activation of gene expression in human neutrophils by high mobility group box 1 protein. Am J Physiol Cell Physiol 2003;284:C870–C879.
   PubMed Web of Science ®Google Scholar
• Palumbo R, Sampaolesi M, De Marchis F, Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004;164:441–449.
   PubMed Web of Science ®Google Scholar
• Messmer D, Yang H, Telusma G, High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. J Immunol 2004;173:307–313.
   PubMed Web of Science ®Google Scholar
• Telusma G, Datta S, Mihajlov I, Dendritic cell activating peptides induce distinct cytokine profiles. Int Immunol 2006;18:1563–1573.
   PubMedGoogle Scholar
• Rouhiainen A, Kuja-Panula J, Wilkman E, Regulation of monocyte migration by amphoterin (HMGB1) Blood 2004;104:1174–1182.
   PubMed Web of Science ®Google Scholar
• Tsung A, Zheng N, Jeyabalan G, Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 2007;81:119–128.
   PubMedGoogle Scholar
• Urbonaviciute V, Fürnrohr BG, Meister S, Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med 2008;205:3007–3018.
   PubMed Web of Science ®Google Scholar
• Ivanov S, Dragoi AM, Wang X, A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA. Blood 2007;110:1970–1981.
   PubMed Web of Science ®Google Scholar
• Tian J, Avalos AM, Mao SY, Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007;8:487–496.
   PubMed Web of Science ®Google Scholar
• Ciucci A, Gabriele I, Percario ZA, HMGB1 and cord blood: its role as immuno-adjuvant factor in innate immunity. PLoS One 2011;6(8):e23766.
   Google Scholar
• Tal MC, Iwasaki A. Autophagy and innate recognition systems. Curr Top Microbiol Immunol 2009;335:107–121.
   PubMedGoogle Scholar
• Faure M, Lafont F. Pathogen-induced autophagy signaling in innate immunity. J Innate Immun May 3, 2013. [Epub ahead of print]
   PubMedGoogle Scholar
• Kang R, Tang D, Schapiro NE, The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival. Cell Death Differ 2010;17:666–676.
   PubMed Web of Science ®Google Scholar
• Kang R, Livesey KM, Zeh HJ 3rd, Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy 2011;7:1256–1258.
   PubMed Web of Science ®Google Scholar
• He Q, You H, Li XM, HMGB1 promotes the synthesis of pro-IL-1β and pro-IL-18 by activation of p38 MAPK and NF-κB through receptors for advanced glycation end-products in macrophages. Asian Pac J Cancer Prev 2012;13:1365–1370.
   PubMedGoogle Scholar
• Yamamoto Y, Harashima A, Saito H, Septic shock is associated with receptor for advanced glycation end products ligation of LPS. J Immunol 2011;186:3248–3257.
   PubMed Web of Science ®Google Scholar
• Ramsgaard L, Englert JM, Manni ML, Lack of the receptor for advanced glycation end-products attenuates E. coli pneumonia in mice. PLoS One 2011;6:e20132.
   PubMed Web of Science ®Google Scholar
• Williams JH, Ireland HE. J Sensing danger–Hsp72 and HMGB1 as candidate signals. J Leuk Biol 2008;83:489–492.
   PubMedGoogle Scholar
• Chiodoni C, Colombo MP, Sangaletti S. Matricellular proteins: from homeostasis to inflammation, cancer, and metastasis. Cancer Metast Rev 2010;29:295–307.
   PubMed Web of Science ®Google Scholar
• Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol 2010;11:785–797.
   PubMed Web of Science ®Google Scholar
• Barber GN. Cytoplasmic DNA innate immune pathways. Immunol Rev 2011;243:99–108.
   PubMed Web of Science ®Google Scholar
• Ruan BH, Li X, Winkler AR, J Immunol 2010;185(7):4213–4222.
   PubMedGoogle Scholar
• Park H, Adsit FG, Boyington JC. The 1.5 Å crystal structure of human receptor for advanced glycation endproducts (RAGE) ectodomains reveals unique features determining ligand binding. J Biol Chem 2010;285(52):40762–40770.
   PubMedGoogle Scholar
• Ma W, Rai V, Hudson BI, RAGE binds C1q and enhances C1q-mediated phagocytosis. Cell Immunol 2012;274:72–82.
   PubMed Web of Science ®Google Scholar
• Devitt A, Marshall LJ. The innate immune system and the clearance of apoptotic cells. J Leukoc Biol 2011;90:447–457.
   PubMedGoogle Scholar
• He M, Kubo H, Morimoto K, Receptor for advanced glycation end products binds to phosphatidylserine and assists in the clearance of apoptotic cells. EMBO Rep 2011;12:358–364.
   PubMed Web of Science ®Google Scholar
• Friggeri A, Banerjee S, Biswas S, Participation of the receptor for advanced glycation end products in efferocytosis. J Immunol 2011;186:6191–6198.
   PubMedGoogle Scholar
• Rojas A, Gonzalez I, Rodriguez B, Evidence of involvement of the receptor for advanced glycation end-products (RAGE) in the adhesion of Helicobacter pylori to gastric epithelial cells. Microb Infec 2011;13:818–823.
   PubMedGoogle Scholar
• Arce-Mendoza A, Rodriguez-de Ita J, Salinas-Carmona MC, Rosas-Taraco AG. Expression of CD64, CD206, and RAGE in adherent cells of diabetic patients infected with Mycobacterium tuberculosis. Arch Med Res 2008;39:306–311.
   PubMedGoogle Scholar
• Tian J, Huang K, Krishnan S, RAGE inhibits RSV syncytia formation by interfering with F-protein function. J Gen Virol April 4, 2013. [Epub ahead of print].
   Google Scholar
• Sorci G, Giovannini G, Riuzzi F, The danger signal S100B integrates pathogen- and danger-sensing pathways to restrain inflammation. PLoS Pathog 2011 7:e1001315.
   PubMed Web of Science ®Google Scholar
• van Zoelen MA, Schouten M, de Vos AF, The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. J Immunol 2009;182:4349–4356.
   PubMed Web of Science ®Google Scholar
• Amir J, Waite M, Tobler J, The role of hyperglycemia in mechanisms of exacerbated inflammatory responses within the oral cavity. Cell Immunol 2011;272:45–52.
   PubMedGoogle Scholar
• Rojas A, Delgado-López F, González I, The receptor for advanced glycation end-products: a complex signaling scenario for a promiscuous receptor. Cell Signal 2013;25:609–614.
   PubMed Web of Science ®Google Scholar
• Nogueira-Machado JA, Volpe CM, Veloso CA, Chaves MM. HMGB1, TLR and RAGE: a functional tripod that leads to diabetic inflammation. Expert Opin Ther Targets 2011;15:1023–1035.
   PubMed Web of Science ®Google Scholar
• Tian J, Avalos AM, Mao SY, Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol 2007;8:487–496.
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Murata H, Yamamoto K, TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding. PLoS One 2011;6:e23132.
   PubMed Web of Science ®Google Scholar
• Chakraborty R, Bhatt KH, Sodhi A. High mobility group box 1 protein synergizes with lipopolysaccharide and peptidoglycan for nitric oxide production in mouse peritoneal macrophages in vitro. Mol Immunol 2013;54:48–57.
   PubMedGoogle Scholar
• Ghavami S, Rashedi I, Dattilo BM, S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J Leukoc Biol 2008;83:1484–1492.
   PubMed Web of Science ®Google Scholar
• Vogl T, Tenbrock K, Ludwig S, Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 2007;13:1042–1049
   PubMed Web of Science ®Google Scholar
• Yeh C, Sturgis L, Haidacher J, Requirement for p38 and p44/42 mitogen-activated protein kinases in RAGE-mediated nuclear factor-kB transcriptional activation and cytokine secretion. Diabetes 2001;50:1495–1504.
   PubMed Web of Science ®Google Scholar
• Huttunen H, Kuja-Panula J, Rauvala H. RAGE signaling induces CREB-dependent chromogranin expression during neuronal differentiation. J Biol Chem 2002;277:38635–38646.
   PubMedGoogle Scholar
• Huang JS, Guh JY, Chen HC, Role of receptor for advanced glycation end-product (RAGE) and the JAK/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001;81:102–113.
   PubMed Web of Science ®Google Scholar
• Yan SF, Ramasamy R, Schmidt AM. Soluble RAGE: therapy and biomarker in unraveling the RAGE axis in chronic disease and aging. Biochem Pharmacol 2010;79:1379–1386.
   PubMed Web of Science ®Google Scholar
• Bierhaus A, Schiekofer S, Schwaninger M, Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001;50:2792–2808.
   PubMed Web of Science ®Google Scholar
• Ogier-Denis E, Mkaddem SB, Vandewalle A. NOX enzymes and Toll-like receptor signaling. Semin Immunopathol 2008;30:291–300.
   Google Scholar
• Guo ZJ, Niu HX, Hou FF, Advanced oxidation protein products activate vascular endothelial cells via a RAGE-mediated signaling pathway. Antioxid Redox Signal 2008;10:1699–1712.
   PubMed Web of Science ®Google Scholar
• Sangle GV, Zhao R, Mizuno TM, Shen GX. Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells. Endocrinology 2010;151:4455–4466
   PubMed Web of Science ®Google Scholar
• Robinson JM, Ohira T, Badwey JA. Regulation of the NADPH-oxidase complex of phagocytic leukocytes. Recent insights from structural biology, molecular genetics, and microscopy. Histochem Cell Biol 2004;122:293–304.
   PubMedGoogle Scholar
• Omori K, Ohira T, Uchida Y, Priming of neutrophil oxidative burst in diabetes requires preassembly of the NADPH oxidase. J Leukoc Biol 2008;84:292–301.
   PubMed Web of Science ®Google Scholar
• Ghoreschi K, Laurence A, O'Shea JJ. Janus kinases in immune cell signaling. Immunol Rev 2009;228:273–287.
   PubMed Web of Science ®Google Scholar
• Kim YK, Park HK, JYoon YS, Advanced glycation end product (AGE)-induced proliferation of HEL cells via receptor for AGE-related signal pathways. Int J Oncol 2008;33:493–501.
   PubMed Web of Science ®Google Scholar
• Yammani RR, Long D, Loeser RF. Interleukin-7 stimulates secretion of S100A4 by activating the JAK/STAT signaling pathway in human articular chondrocytes. Arth Rheum 2009;60:792–800.
   PubMed Web of Science ®Google Scholar
• McGettrick AF, O'Neill LA. Localisation and trafficking of Toll-like receptors: an important mode of regulation. Curr Opin Immunol 2010;22:20–27.
   PubMed Web of Science ®Google Scholar
• Sevillano N, Girón MD, Salido M, Internalization of the receptor for advanced glycation end products (RAGE) is required to mediate intracellular responses. J Biochem 2009;145:21–30.
   PubMedGoogle Scholar
• Akirav EM, Preston-Hurlburt P, Garyu J, RAGE expression in human T cells: a link between environmental factors and adaptive immune responses. PLoS One 2012;7(4):e34698.
   Google Scholar